ReviewJournal of personalized medicine2023
Predicting the Onset of Diabetes with Machine Learning Methods.
Review in Journal of personalized medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
31 citing papers in PubMed.
- Review
- A Sophisticated Onscreen Smart Framework for Predicting Diabetes in Remote Healthcare.Diagnostics (Basel, Switzerland) · 2026Article
- Ranolazine attenuates diabetic cardiomyopathy in rats by suppressing AGE-RAGE axis and oxidative stress.BMC research notes · 2026Article
- Pediatric diabetes prediction using machine learning.Scientific reports · 2026Article
- Risk factors for type 2 diabetes mellitus among university students in Saudi Arabia: a multi-regional cross-sectional study.Frontiers in endocrinology · 2026Observational
- Cellulose nanocrystal/polyacrylic acid nanofiber composite aerogels characterized by 3D porous structure for colorimetric detection of breath acetone.Mikrochimica acta · 2025Article
- Application of machine learning for early detection of chronic diseases in Africa.Journal of public health research · 2025Article
- Using a robust model to detect the association between anthropometric factors and T2DM: machine learning approaches.BMC medical informatics and decision making · 2025Article
- Gypenosides, a promising phytochemical triterpenoid: research progress on its pharmacological activity and mechanism.Frontiers in pharmacology · 2025Review
- Unveiling diabetes onset: Optimized XGBoost with Bayesian optimization for enhanced prediction.PloS one · 2025Article
- Article
- Sex-Specific Ensemble Models for Type 2 Diabetes Classification in the Mexican Population.Diabetes, metabolic syndrome and obesity : targets and therapy · 2025Article
- Impact of machine learning on dietary and exercise behaviors in type 2 diabetes self-management: a systematic literature review.PeerJ. Computer science · 2025Article
- Predicting nursing workload in digestive wards based on machine learning: A prospective study.BMC nursing · 2024Article
- Leveraging Shapley Additive Explanations for Feature Selection in Ensemble Models for Diabetes Prediction.Bioengineering (Basel, Switzerland) · 2024Article
- Robust diabetic prediction using ensemble machine learning models with synthetic minority over-sampling technique.Scientific reports · 2024Article
- Sialic acids cleavage induced by elastin-derived peptides impairs the interaction between insulin and its receptor in adipocytes 3T3-L1.Journal of physiology and biochemistry · 2024Article
- Predicting Male Infertility Using Artificial Neural Networks: A Review of the Literature.Healthcare (Basel, Switzerland) · 2024Review
- Characterization of Plant-Derived Natural Inhibitors of Dipeptidyl Peptidase-4 as Potential Antidiabetic Agents: A Computational Study.Pharmaceutics · 2024Article
- Ethical and regulatory challenges of AI technologies in healthcare: A narrative review.Heliyon · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The number of people suffering from diabetes in Taiwan has continued to rise in recent years. According to the statistics of the International Diabetes Federation, about 537 million people worldwide (10.5% of the global population) suffer from diabetes, and it is estimated that 643 million people will develop the condition (11.3% of the total population) by 2030. If this trend continues, the number will jump to 783 million (12.2%) by 2045. At present, the number of people with diabetes in Taiwan has reached 2.18 million, with an average of one in ten people suffering from the disease. In addition, according to the Bureau of National Health Insurance in Taiwan, the prevalence rate of diabetes among adults in Taiwan has reached 5% and is increasing each year. Diabetes can cause acute and chronic complications that can be fatal. Meanwhile, chronic complications can result in a variety of disabilities or organ decline. If holistic treatments and preventions are not provided to diabetic patients, it will lead to the consumption of more medical resources and a rapid decline in the quality of life of society as a whole. In this study, based on the outpatient examination data of a Taipei Municipal medical center, 15,000 women aged between 20 and 80 were selected as the subjects. These women were patients who had gone to the medical center during 2018-2020 and 2021-2022 with or without the diagnosis of diabetes. This study investigated eight different characteristics of the subjects, including the number of pregnancies, plasma glucose level, diastolic blood pressure, sebum thickness, insulin level, body mass index, diabetes pedigree function, and age. After sorting out the complete data of the patients, this study used Microsoft Machine Learning Studio to train the models of various kinds of neural networks, and the prediction results were used to compare the predictive ability of the various parameters for diabetes. Finally, this study found that after comparing the models using two-class logistic regression as well as the two-class neural network, two-class decision jungle, or two-class boosted decision tree for prediction, the best model was the two-class boosted decision tree, as its area under the curve could reach a score of 0.991, which was better than other models.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.